Figure 1From: Immunomodulatory responses of peripheral blood mononuclear cells from multiple sclerosis patients upon in vitro incubation with the flavonoid luteolin: additive effects of IFN-βDose-dependent effects of luteolin in combination with 2 IU of IFN-β upon PHA-dependent proliferative responses. PBMCs derived from MS patients were incubated in the presence of 0.2-50 μM luteolin and 0.2-10 μM luteolin in combination with 2IU IFN-β. Values expressed are a percentage of maximum response (% of control). Data is average mean ± SE of 14 MS patients. Abbrev: Lu = luteolin.Back to article page